Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cyclosporin A binding	RANBP2 NKTR PPIA PPID	3.34e-06	24	87	4	GO:0016018
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	RANBP2 NKTR PPIA PPID	6.64e-05	50	87	4	GO:0003755
GeneOntologyMolecularFunction	cis-trans isomerase activity	RANBP2 NKTR PPIA PPID	8.36e-05	53	87	4	GO:0016859
GeneOntologyMolecularFunction	peptidase activator activity	CASP8 APP ATP2A3 PCOLCE	2.48e-04	70	87	4	GO:0016504
GeneOntologyMolecularFunction	3-hydroxyacyl-CoA dehydrogenase activity	HADHA HSD17B4	2.78e-04	6	87	2	GO:0003857
GeneOntologyMolecularFunction	carbon-oxygen lyase activity	NEIL1 NTHL1 HADHA HSD17B4	4.54e-04	82	87	4	GO:0016835
GeneOntologyMolecularFunction	3-hydroxyacyl-CoA dehydratase activity	HADHA HSD17B4	5.17e-04	8	87	2	GO:0018812
GeneOntologyMolecularFunction	class I DNA-(apurinic or apyrimidinic site) endonuclease activity	NEIL1 NTHL1	5.17e-04	8	87	2	GO:0140078
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL3A1 COL5A1 COL19A1	1.06e-03	46	87	3	GO:0030020
GeneOntologyMolecularFunction	enoyl-CoA hydratase activity	HADHA HSD17B4	1.20e-03	12	87	2	GO:0004300
GeneOntologyMolecularFunction	platelet-derived growth factor binding	COL3A1 COL5A1	1.20e-03	12	87	2	GO:0048407
GeneOntologyMolecularFunction	chromatin binding	RAD51 NCOA6 ZNF609 SUPT5H RCC1 KDM1B APP TAF1L PRDM15 DNMT3B	1.39e-03	739	87	10	GO:0003682
GeneOntologyMolecularFunction	isomerase activity	RANBP2 NKTR HSD17B4 PPIA PPID	1.52e-03	192	87	5	GO:0016853
GeneOntologyMolecularFunction	DNA N-glycosylase activity	NEIL1 NTHL1	1.65e-03	14	87	2	GO:0019104
GeneOntologyMolecularFunction	DNA-(apurinic or apyrimidinic site) endonuclease activity	NEIL1 NTHL1	1.65e-03	14	87	2	GO:0003906
GeneOntologyBiologicalProcess	peptidyl-proline modification	RANBP2 OGFOD1 NKTR PPIA PPID	3.19e-06	54	87	5	GO:0018208
GeneOntologyBiologicalProcess	protein peptidyl-prolyl isomerization	RANBP2 NKTR PPIA PPID	1.95e-05	38	87	4	GO:0000413
Domain	Cyclophilin-type_PPIase_CS	RANBP2 NKTR PPIA PPID	1.54e-06	19	86	4	IPR020892
Domain	Cyclophilin-like_dom	RANBP2 NKTR PPIA PPID	2.88e-06	22	86	4	IPR029000
Domain	CSA_PPIASE_2	RANBP2 NKTR PPIA PPID	2.88e-06	22	86	4	PS50072
Domain	Pro_isomerase	RANBP2 NKTR PPIA PPID	2.88e-06	22	86	4	PF00160
Domain	-	RANBP2 NKTR PPIA PPID	2.88e-06	22	86	4	2.40.100.10
Domain	Cyclophilin-type_PPIase_dom	RANBP2 NKTR PPIA PPID	2.88e-06	22	86	4	IPR002130
Domain	CSA_PPIASE_1	RANBP2 NKTR PPIA PPID	2.88e-06	22	86	4	PS00170
Domain	Cyclophilin-type_PPIase	NKTR PPIA PPID	1.18e-04	21	86	3	IPR024936
Domain	Cadherin_cytoplasmic-dom	CDH22 DSC1 CDH12	2.01e-04	25	86	3	IPR000233
Domain	Cadherin_C	CDH22 DSC1 CDH12	2.01e-04	25	86	3	PF01049
Domain	Catenin_binding_dom	CDH22 DSC1 CDH12	3.16e-04	29	86	3	IPR027397
Domain	-	CDH22 DSC1 CDH12	3.16e-04	29	86	3	4.10.900.10
Domain	HHH	RAD51 NTHL1	4.34e-04	7	86	2	PF00633
Domain	HhH_motif	RAD51 NTHL1	4.34e-04	7	86	2	IPR000445
Domain	TPR_7	NPHP3 PPID	9.21e-04	10	86	2	PF13176
Domain	Fib_collagen_C	COL3A1 COL5A1	1.12e-03	11	86	2	IPR000885
Domain	COLFI	COL3A1 COL5A1	1.12e-03	11	86	2	PF01410
Domain	NC1_FIB	COL3A1 COL5A1	1.12e-03	11	86	2	PS51461
Domain	FYVE_2	SYTL5 SYTL2	1.12e-03	11	86	2	PF02318
Domain	Fib_collagen_C	COL3A1 COL5A1	1.12e-03	11	86	2	PD002078
Domain	COLFI	COL3A1 COL5A1	1.12e-03	11	86	2	SM00038
Domain	RABBD	SYTL5 SYTL2	1.34e-03	12	86	2	PS50916
Domain	Rab_BD	SYTL5 SYTL2	1.34e-03	12	86	2	IPR010911
Domain	CUB	CSMD1 CSMD2 PCOLCE	1.49e-03	49	86	3	PF00431
Domain	CUB	CSMD1 CSMD2 PCOLCE	1.58e-03	50	86	3	SM00042
Domain	Cadherin_CS	CDH22 DSC1 PCDHGB3 CDH12	1.61e-03	109	86	4	IPR020894
Domain	-	CSMD1 CSMD2 PCOLCE	1.77e-03	52	86	3	2.60.120.290
Domain	Sushi	SUSD5 CSMD1 CSMD2	1.77e-03	52	86	3	PF00084
Domain	CADHERIN_1	CDH22 DSC1 PCDHGB3 CDH12	1.84e-03	113	86	4	PS00232
Domain	Cadherin	CDH22 DSC1 PCDHGB3 CDH12	1.84e-03	113	86	4	PF00028
Domain	CUB	CSMD1 CSMD2 PCOLCE	1.87e-03	53	86	3	PS01180
Domain	CADHERIN_2	CDH22 DSC1 PCDHGB3 CDH12	1.90e-03	114	86	4	PS50268
Domain	-	CDH22 DSC1 PCDHGB3 CDH12	1.90e-03	114	86	4	2.60.40.60
Domain	CA	CDH22 DSC1 PCDHGB3 CDH12	1.96e-03	115	86	4	SM00112
Domain	CCP	SUSD5 CSMD1 CSMD2	1.97e-03	54	86	3	SM00032
Domain	Cadherin-like	CDH22 DSC1 PCDHGB3 CDH12	2.03e-03	116	86	4	IPR015919
Domain	Cadherin	CDH22 DSC1 PCDHGB3 CDH12	2.16e-03	118	86	4	IPR002126
Domain	SUSHI	SUSD5 CSMD1 CSMD2	2.19e-03	56	86	3	PS50923
Domain	Sushi_SCR_CCP_dom	SUSD5 CSMD1 CSMD2	2.31e-03	57	86	3	IPR000436
Domain	CUB_dom	CSMD1 CSMD2 PCOLCE	2.31e-03	57	86	3	IPR000859
Domain	Laminin_G	COL5A1 NRXN3 COL19A1	2.42e-03	58	86	3	IPR001791
Domain	Rib_L2_dom2	SUPT5H HERC2	3.06e-03	18	86	2	IPR014722
Domain	-	SUPT5H HERC2	3.06e-03	18	86	2	2.30.30.30
Domain	TPR_repeat	RANBP2 NPHP3 PPID LRP2BP	3.33e-03	133	86	4	IPR019734
Domain	RCC1	RCC1 HERC2	3.77e-03	20	86	2	PF00415
Domain	RCC1_1	RCC1 HERC2	4.16e-03	21	86	2	PS00625
Domain	RCC1_2	RCC1 HERC2	4.16e-03	21	86	2	PS00626
Domain	RCC1_3	RCC1 HERC2	4.16e-03	21	86	2	PS50012
Domain	zf-RanBP	RANBP2 ZRANB1	4.56e-03	22	86	2	PF00641
Domain	Reg_chr_condens	RCC1 HERC2	4.56e-03	22	86	2	IPR000408
Domain	-	RCC1 HERC2	4.56e-03	22	86	2	2.130.10.30
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL3A1 COL5A1 COL19A1 PCOLCE	1.66e-04	61	64	4	MM14637
Pathway	BIOCARTA_RAN_PATHWAY	RANBP2 RCC1	2.01e-04	5	64	2	M22082
Pathway	REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR	NEIL1 NTHL1	2.01e-04	5	64	2	M29801
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL3A1 COL5A1 COL19A1 PCOLCE	2.39e-04	67	64	4	M26999
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	SLC8A3 ATP2A3 ITPR2	2.42e-04	27	64	3	MM15053
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	SLC8A3 ATP2A3 ITPR2	2.70e-04	28	64	3	M924
Pathway	WP_ALZHEIMERS_DISEASE	CASP8 APP ATP2A3 ITPR2	3.50e-04	74	64	4	MM15962
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PDE2A SLC8A3 ATP2A3 ITPR2	3.88e-04	76	64	4	MM15051
Pathway	REACTOME_COLLAGEN_FORMATION	COL3A1 COL5A1 COL19A1 PCOLCE	3.88e-04	76	64	4	MM14573
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	COL3A1 COL5A1 DDR2	4.03e-04	32	64	3	MM14924
Pathway	REACTOME_CLEAVAGE_OF_THE_DAMAGED_PYRIMIDINE	NEIL1 NTHL1	5.58e-04	8	64	2	MM14478
Pathway	REACTOME_HIV_LIFE_CYCLE	RANBP2 SUPT5H RCC1 PPIA TAF1L	5.69e-04	149	64	5	M4076
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PDE2A SLC8A3 ATP2A3 ITPR2	6.21e-04	86	64	4	M916
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SCAF1 NCOA6 RANBP2 ZNF609 SF3B3 SNW1 ZCCHC8 SUPT5H NTHL1 AHNAK HTATSF1 RCC1 DDX51 NKTR HADHA KDM1B TAF1L BHLHE40	2.80e-09	1294	87	18	30804502
Pubmed	Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases.	RANBP2 NKTR PPIA PPID	4.88e-08	15	87	4	20676357
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	RANBP2 SF3B3 SUPT5H HTATSF1 ANP32E RCC1 DNMT3B	1.06e-07	150	87	7	28242625
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RANBP2 SF3B3 SNW1 MAP2 ZCCHC8 SUPT5H HIC2 RCC1 HADHA KDM1B HSD17B4 PPIA HSDL1 DNMT3B	4.79e-07	1082	87	14	38697112
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	COL5A1 SCAF1 MYOF NCOA6 RANBP2 CDH22 NPHP3 SNW1	5.83e-07	283	87	8	18854154
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	SCAF1 RANBP2 SF3B3 SNW1 DSC1 ZCCHC8 SUPT5H AHNAK ANP32E RCC1 DDX51 HADHA PPIA	1.08e-06	989	87	13	36424410
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	SCAF1 RANBP2 SF3B3 SNW1 SUPT5H AHNAK RCC1 HADHA HERC2 APP HSD17B4 PPIA ITPR2	1.58e-06	1024	87	13	24711643
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SCAF1 PCDHGB3 AHNAK IQSEC2 TTI2 ANP32E HIC2 HADHA CSMD2 CABLES1 ITPR2	2.30e-06	736	87	11	29676528
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	DNAJB12 SGPL1 AHNAK RCC1 HADHA APP HSD17B4 GTPBP1 PPIA HSDL1 CD99L2 ITPR2	4.45e-06	952	87	12	38569033
Pubmed	A yeast genetic assay for caspase cleavage of the amyloid-beta precursor protein.	CASP8 APP	6.19e-06	2	87	2	10911620
Pubmed	Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.	CSMD1 CSMD2	6.19e-06	2	87	2	24408017
Pubmed	Embryonic expression pattern of amyloid protein precursor suggests a role in differentiation of specific subsets of neurons.	MAP2 APP	6.19e-06	2	87	2	8207383
Pubmed	Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2.	UBE3A HERC2	6.19e-06	2	87	2	21493713
Pubmed	Stereoselective excision of thymine glycol from oxidatively damaged DNA.	NEIL1 NTHL1	6.19e-06	2	87	2	14726482
Pubmed	Interaction properties of the procollagen C-proteinase enhancer protein shed light on the mechanism of stimulation of BMP-1.	COL3A1 PCOLCE	6.19e-06	2	87	2	12105202
Pubmed	Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate alpha2beta1 integrin, and recruit alphavbeta3 Instead of alpha5beta1 integrin.	COL3A1 COL5A1	6.19e-06	2	87	2	14970208
Pubmed	Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion.	PPIA PPID	6.19e-06	2	87	2	21711559
Pubmed	A genetic association study of CSMD1 and CSMD2 with cognitive function.	CSMD1 CSMD2	6.19e-06	2	87	2	27890662
Pubmed	The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.	CSMD1 CSMD2	6.19e-06	2	87	2	21439553
Pubmed	A DNA oligomer containing 2,2,4-triamino-5(2H)-oxazolone is incised by human NEIL1 and NTH1.	NEIL1 NTHL1	6.19e-06	2	87	2	22465744
Pubmed	Repair of thymine glycol by hNth1 and hNeil1 is modulated by base pairing and cis-trans epimerization.	NEIL1 NTHL1	6.19e-06	2	87	2	16446124
Pubmed	DNA glycosylase activities for thymine residues oxidized in the methyl group are functions of the hNEIL1 and hNTH1 enzymes in human cells.	NEIL1 NTHL1	6.19e-06	2	87	2	15533839
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MYOF RANBP2 LPCAT1 SF3B3 SNW1 DSC1 SUPT5H AHNAK HTATSF1 ANP32E HADHA HSD17B4 GTPBP1 PPID	7.27e-06	1367	87	14	32687490
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	DNAJB12 RANBP2 SF3B3 SNW1 UBE3A SUPT5H AHNAK HTATSF1 ANP32E RCC1 KDM1B PPID	8.41e-06	1014	87	12	32416067
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	COL3A1 NEK4 DNAJB12 COL5A1 MYOF BPNT2 MELTF SGPL1 TMCO3 APP ATP2A3 ITPR2 PCOLCE	8.90e-06	1201	87	13	35696571
Pubmed	Identification and characterization of the potential promoter regions of 1031 kinds of human genes.	RAD51 MELTF HERC2 PPIA	9.02e-06	52	87	4	11337467
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RANBP2 HSPA12A SNX4 ZNF609 SUPT5H AHNAK RCC1 HADHA HERC2 APP HSD17B4 ITPR2	1.18e-05	1049	87	12	27880917
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RANBP2 NRXN3 SF3B3 ABCB9 PCDHGB3 AHNAK ADAM7 RCC1 HADHA HSD17B4 ATP2A3 ZEB2 PLXNA2 DNMT3B	1.33e-05	1442	87	14	35575683
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	UBE3A SUPT5H NKTR HERC2 ZRANB1 ITPR2	1.60e-05	212	87	6	33853758
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PDE2A KLHL7 UBE3A ZCCHC8 SUPT5H IQSEC2 HERC2 APP HSD17B4 BHLHE40 ZEB2 RUFY3 AGAP3	1.82e-05	1285	87	13	35914814
Pubmed	Identification of two new members of the CSMD gene family.	CSMD1 CSMD2	1.85e-05	3	87	2	12906867
Pubmed	Involvement of Hsp90 and cyclophilins in intoxication by AIP56, a metalloprotease toxin from Photobacterium damselae subsp. piscicida.	PPIA PPID	1.85e-05	3	87	2	31227743
Pubmed	Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.	SUPT5H HTATSF1	1.85e-05	3	87	2	15564463
Pubmed	Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction.	NCOA6 MAP2	1.85e-05	3	87	2	12556486
Pubmed	Collagen Family Genes Associated with Risk of Recurrence after Radiation Therapy for Vestibular Schwannoma and Pan-Cancer Analysis.	COL3A1 COL5A1	1.85e-05	3	87	2	34691289
Pubmed	Distribution of collagen types I, III, and V in pregnant mouse endometrium.	COL3A1 COL5A1	1.85e-05	3	87	2	17453912
Pubmed	A novel ER J-protein DNAJB12 accelerates ER-associated degradation of membrane proteins including CFTR.	DNAJB12 APP	1.85e-05	3	87	2	21150129
Pubmed	Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease.	SLC8A3 APP	1.85e-05	3	87	2	23919677
Pubmed	Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA.	NEIL1 NTHL1	1.85e-05	3	87	2	19346169
Pubmed	Interaction between very-KIND Ras guanine exchange factor and microtubule-associated protein 2, and its role in dendrite growth--structure and function of the second kinase noncatalytic C-lobe domain.	MAP2 FRMPD2	1.85e-05	3	87	2	21385318
Pubmed	Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes.	NEIL1 NTHL1	1.85e-05	3	87	2	16221681
Pubmed	miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression.	COL3A1 COL5A1	1.85e-05	3	87	2	33819468
Pubmed	Differential specificity of human and Escherichia coli endonuclease III and VIII homologues for oxidative base lesions.	NEIL1 NTHL1	1.85e-05	3	87	2	14734554
Pubmed	DSIF, the Paf1 complex, and Tat-SF1 have nonredundant, cooperative roles in RNA polymerase II elongation.	SUPT5H HTATSF1	1.85e-05	3	87	2	19952111
Pubmed	Damage specificity of human DNA glycosylases for oxidative pyrimidine lesions.	NEIL1 NTHL1	1.85e-05	3	87	2	17150535
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	LPCAT1 HSPA12A ABCB9 NEIL1 SUPT5H AHNAK IQSEC2 HIC2 APP HSD17B4 DNMT3B	1.97e-05	925	87	11	28986522
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RAD51 SCAF1 MYOF NCOA6 PDE2A EFNA2 AHNAK HERC2 ATP2A3 CABLES1 AGAP3 ITPR2	1.97e-05	1105	87	12	35748872
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	RANBP2 SNW1 ZCCHC8 SUPT5H AHNAK HTATSF1 RCC1 ZEB2	2.37e-05	469	87	8	27634302
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NCOA6 RANBP2 ZNF609 SF3B3 SNW1 AHNAK HTATSF1 CASP8 RCC1 PPIA TAF1L	2.62e-05	954	87	11	36373674
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	RANBP2 SF3B3 DSC1 AHNAK HTATSF1 NKTR HADHA PPIA	2.68e-05	477	87	8	31300519
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	MYOF RANBP2 LPCAT1 ANP32E HADHA APP	2.86e-05	235	87	6	28378594
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RANBP2 SF3B3 SNW1 DSC1 UBE3A SGPL1 AHNAK CASP8 RCC1 DDX51 HADHA HERC2 PPIA	3.11e-05	1353	87	13	29467282
Pubmed	Reduced expression of Na+/Ca2+ exchangers is associated with cognitive deficits seen in Alzheimer's disease model mice.	SLC8A3 APP	3.70e-05	4	87	2	29274751
Pubmed	HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.	RANBP2 PPIA	3.70e-05	4	87	2	22174692
Pubmed	Interactions between collagen gene variants and risk of anterior cruciate ligament rupture.	COL3A1 COL5A1	3.70e-05	4	87	2	25073002
Pubmed	Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a.	MAP2 UBE3A	3.70e-05	4	87	2	12668607
Pubmed	SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets.	ATP2A3 ITPR2	3.70e-05	4	87	2	18068335
Pubmed	Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.	APP PPID	3.70e-05	4	87	2	18806802
Pubmed	Cyclophilin D deficiency attenuates mitochondrial F1Fo ATP synthase dysfunction via OSCP in Alzheimer's disease.	APP PPID	3.70e-05	4	87	2	30266287
Pubmed	Collagen XXIV, a vertebrate fibrillar collagen with structural features of invertebrate collagens: selective expression in developing cornea and bone.	COL3A1 COL5A1	3.70e-05	4	87	2	12874293
Pubmed	DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8.	CASP8 DNMT3B	3.70e-05	4	87	2	20398055
Pubmed	AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.	MYOF AHNAK	3.70e-05	4	87	2	17185750
Pubmed	Multiple cyclophilins involved in different cellular pathways mediate HCV replication.	PPIA PPID	3.70e-05	4	87	2	19932913
Pubmed	The Multimerization State of the Amyloid-β42 Amyloid Peptide Governs its Interaction Network with the Extracellular Matrix.	APP PCOLCE	3.70e-05	4	87	2	28106549
Pubmed	Extended interaction network of procollagen C-proteinase enhancer-1 in the extracellular matrix.	APP PCOLCE	3.70e-05	4	87	2	24117177
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	COL5A1 RANBP2 SNW1 ZCCHC8 SUPT5H AHNAK DDX51 HADHA HERC2	3.83e-05	653	87	9	22586326
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	SCAF1 NRXN3 ZCCHC8 SUPT5H HTATSF1 GTPBP1	4.12e-05	251	87	6	28077445
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	DNAJB12 COL5A1 MYOF RANBP2 SF3B3 ZCCHC8 SGPL1 AHNAK TTI2 ANP32E RCC1 HADHA ITPR2	5.88e-05	1440	87	13	30833792
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	SF3B3 UBE3A AHNAK DZIP3 HERC2 TAF1L	6.05e-05	269	87	6	29511261
Pubmed	Functional constraints on HIV-1 capsid: their impacts on the viral immune escape potency.	RANBP2 PPIA	6.16e-05	5	87	2	23087682
Pubmed	Co-activation of RanGTPase and inhibition of GTP dissociation by Ran-GTP binding protein RanBP1.	RANBP2 RCC1	6.16e-05	5	87	2	7882974
Pubmed	HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.	RANBP2 PPIA	6.16e-05	5	87	2	26109731
Pubmed	Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production.	MAP2 APP	6.16e-05	5	87	2	19357271
Pubmed	A model for cofactor use during HIV-1 reverse transcription and nuclear entry.	RANBP2 PPIA	6.16e-05	5	87	2	24525292
Pubmed	Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.	APP PPID	6.16e-05	5	87	2	21958963
Pubmed	Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells.	COL3A1 COL5A1	6.16e-05	5	87	2	14758483
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	RANBP2 SF3B3 SNW1 AHNAK HADHA PPIA	6.31e-05	271	87	6	32433965
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RAD51 DNAJB12 MYOF NCOA6 RANBP2 ZNF609 SF3B3 SNW1 HADHA APP PPIA PPID	6.36e-05	1247	87	12	27684187
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	MYOF SF3B3 DSC1 AHNAK HADHA PPIA ATP2A3	6.39e-05	397	87	7	21319273
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	COL3A1 MYOF SF3B3 SNW1 DSC1 KLHL7 SGPL1 AHNAK HADHA GTPBP1 PPIA ITPR2	6.86e-05	1257	87	12	36526897
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DNAJB12 COL5A1 ZNF609 MAP2 NEIL1 KIAA0232 MYT1 FRMPD2 CSMD1 APP PRDM15 ZRANB1 AGAP3	8.25e-05	1489	87	13	28611215
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MYOF RANBP2 ZNF609 SF3B3 SNW1 KLHL7 AHNAK HADHA GTPBP1	8.44e-05	724	87	9	36232890
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DNAJB12 SCAF1 MYOF RANBP2 ZCCHC8 SGPL1 NTHL1 DDX51 KDM1B HERC2 APP TAF1L AGAP3	8.70e-05	1497	87	13	31527615
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAD51 RANBP2 ZNF609 ZCCHC8 AHNAK RCC1 ZEB2	8.81e-05	418	87	7	34709266
Pubmed	ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development.	COL3A1 COL5A1	9.22e-05	6	87	2	17029294
Pubmed	The discoidin domain receptor tyrosine kinases are activated by collagen.	COL3A1 DDR2	9.22e-05	6	87	2	9659899
Pubmed	CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.	RAD51 CASP8	9.22e-05	6	87	2	19214744
Pubmed	HIV: Slipping under the radar.	RANBP2 PPIA	9.22e-05	6	87	2	24196714
Pubmed	Expression of two type II cadherins, Cdh12 and Cdh22 in the developing and adult mouse brain.	CDH22 CDH12	9.22e-05	6	87	2	20723620
Pubmed	AP endonuclease-independent DNA base excision repair in human cells.	NEIL1 NTHL1	9.22e-05	6	87	2	15260972
Pubmed	A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue.	NEIL1 NTHL1	9.22e-05	6	87	2	12200441
Pubmed	Both raft- and non-raft proteins associate with CHAPS-insoluble complexes: some APP in large complexes.	APP PPIA	9.22e-05	6	87	2	12927782
Pubmed	Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy.	COL3A1 COL5A1	9.22e-05	6	87	2	3571333
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	MYOF RANBP2 MELTF SF3B3 SUPT5H AHNAK PPIA	9.35e-05	422	87	7	27342126
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SCAF1 LPCAT1 ZNF609 SF3B3 ZCCHC8 SGPL1 HIC2 KDM1B CSMD1 APP AGAP3	1.07e-04	1116	87	11	31753913
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	SCAF1 RANBP2 SF3B3 SNW1 KLHL7 AHNAK ANP32E NKTR HADHA HSD17B4 GTPBP1 PPIA	1.07e-04	1318	87	12	30463901
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	NEK4 ZNF609 NPHP3 SF3B3 KLHL7 SUPT5H AHNAK IQSEC2 DZIP3 NKTR PPID AGAP3	1.10e-04	1321	87	12	27173435
Pubmed	Functional proteomics mapping of a human signaling pathway.	NCOA6 UBE3A ZCCHC8 SUPT5H SYTL2 HTATSF1 HERC2 ZEB2	1.19e-04	591	87	8	15231748
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	SLC8A3 ATP2A3 ITPR2	1.20e-04	38	87	3	30786075
Pubmed	Transcription-coupled nucleotide excision repair is coordinated by ubiquitin and SUMO in response to ultraviolet irradiation.	SF3B3 HTATSF1 RCC1 PPIA	1.29e-04	102	87	4	31722399
Interaction	DDR2 interactions	COL3A1 NEK4 DSC1 SGPL1 DDR2 HADHA HERC2	2.03e-06	136	87	7	int:DDR2
Interaction	U2SURP interactions	NEK4 RANBP2 SF3B3 SNW1 NEIL1 SUPT5H HADHA HERC2 PPIA ZRANB1	2.62e-06	349	87	10	int:U2SURP
Interaction	TAFA4 interactions	NRXN3 SUSD5 APP PLXNA2 ITPR2	3.92e-06	55	87	5	int:TAFA4
Interaction	CCNL1 interactions	CASP8 HERC2 APP PPIA ZRANB1	1.04e-05	67	87	5	int:CCNL1
Interaction	STRIP2 interactions	NEK4 KLHL7 SUPT5H APP ZRANB1	1.12e-05	68	87	5	int:STRIP2
Interaction	MECP2 interactions	RANBP2 SF3B3 SNW1 MAP2 ZCCHC8 SUPT5H HIC2 RCC1 DDX51 NKTR HADHA KDM1B HSD17B4 PPIA ZRANB1 HSDL1 DNMT3B	3.06e-05	1287	87	17	int:MECP2
Interaction	GPALPP1 interactions	SF3B3 PPIA PPID ZRANB1	3.85e-05	44	87	4	int:GPALPP1
Interaction	IK interactions	RANBP2 SNW1 SUPT5H HTATSF1 APP PPIA ZRANB1	4.05e-05	215	87	7	int:IK
Interaction	NUP153 interactions	RANBP2 SNW1 KLHL7 RCC1 HERC2 PPIA ZRANB1	4.17e-05	216	87	7	int:NUP153
Interaction	RTF1 interactions	SUPT5H HADHA APP PPIA ZRANB1 DNMT3B	4.73e-05	150	87	6	int:RTF1
Interaction	SDF4 interactions	NEK4 DNAJB12 RCC1 APP PPIA ZRANB1	4.91e-05	151	87	6	int:SDF4
Interaction	RGPD3 interactions	NEK4 RANBP2 RCC1 ZRANB1	5.02e-05	47	87	4	int:RGPD3
Interaction	FLCN interactions	ZNF609 SF3B3 AHNAK APP AGAP3	7.28e-05	100	87	5	int:FLCN
Interaction	BLM interactions	RAD51 NEK4 SNW1 SUPT5H CASP8 HERC2 PPIA	7.89e-05	239	87	7	int:BLM
Interaction	STAG1 interactions	SF3B3 SNW1 DSC1 PPIA ZRANB1	8.78e-05	104	87	5	int:STAG1
Interaction	KIF21A interactions	RAD51 SNW1 HADHA ZRANB1 CD99L2	9.18e-05	105	87	5	int:KIF21A
Interaction	WBP4 interactions	SF3B3 SNW1 HTATSF1 PPIA ZRANB1	1.10e-04	109	87	5	int:WBP4
Interaction	BPY2 interactions	UBE3A PPIA	1.10e-04	4	87	2	int:BPY2
Interaction	LGSN interactions	NEK4 RANBP2	1.10e-04	4	87	2	int:LGSN
Interaction	PCDHGC5 interactions	NEK4 BPNT2 APP	1.13e-04	22	87	3	int:PCDHGC5
Interaction	EPCAM interactions	DDR2 HERC2 ZRANB1	1.13e-04	22	87	3	int:EPCAM
Interaction	RECQL5 interactions	RAD51 SCAF1 RANBP2 SUPT5H ZRANB1	1.35e-04	114	87	5	int:RECQL5
Interaction	PSMD8 interactions	MAP2 UBE3A APP PPIA PPID ZRANB1	1.38e-04	182	87	6	int:PSMD8
Interaction	EPS8L2 interactions	SNW1 APP PPIA ZRANB1	1.40e-04	61	87	4	int:EPS8L2
Interaction	PLOD3 interactions	NEK4 DNAJB12 AHNAK HADHA PPIA ZRANB1	1.42e-04	183	87	6	int:PLOD3
Interaction	ECI2 interactions	UBE3A HERC2 APP HSD17B4 ZRANB1	1.47e-04	116	87	5	int:ECI2
Interaction	ENY2 interactions	HSPA12A SF3B3 HERC2 APP PPIA ZRANB1	1.55e-04	186	87	6	int:ENY2
Interaction	PML interactions	RAD51 NEK4 RANBP2 ZNF609 SNW1 UBE3A AHNAK CASP8 APP PPIA BHLHE40 AGAP3 ITPR2	1.76e-04	933	87	13	int:PML
Interaction	AFG3L1P interactions	UBE3A APP	1.83e-04	5	87	2	int:AFG3L1P
Interaction	SF3B6 interactions	SF3B3 SNW1 HTATSF1 RCC1 APP ZRANB1	1.95e-04	194	87	6	int:SF3B6
Interaction	ISOC2 interactions	APP GTPBP1 PPIA ZRANB1	2.02e-04	67	87	4	int:ISOC2
Interaction	CLP1 interactions	EFNA2 SNW1 SUPT5H APP	2.02e-04	67	87	4	int:CLP1
Interaction	RNF123 interactions	SCAF1 PCDHGB3 AHNAK IQSEC2 TTI2 ANP32E HIC2 HADHA APP CSMD2 CABLES1 ITPR2	2.13e-04	824	87	12	int:RNF123
Interaction	EXOSC7 interactions	SNW1 ZCCHC8 SUPT5H APP ZRANB1	2.24e-04	127	87	5	int:EXOSC7
Interaction	B3GALT6 interactions	HADHA ATP2A3 ZRANB1	2.35e-04	28	87	3	int:B3GALT6
Interaction	H2AX interactions	RAD51 NEK4 RANBP2 NEIL1 SUPT5H HTATSF1 RCC1 PPIA ZRANB1 DNMT3B	2.36e-04	593	87	10	int:H2AX
Interaction	LGALS3BP interactions	NEK4 COL5A1 MYOF DDR2 HERC2 APP ZRANB1	2.39e-04	286	87	7	int:LGALS3BP
Interaction	SUMO1 interactions	RAD51 RANBP2 UBE3A CASP8 RCC1 ZRANB1 DNMT3B	2.44e-04	287	87	7	int:SUMO1
Interaction	SNCA interactions	SNW1 MAP2 ZCCHC8 SGPL1 AHNAK APP HSD17B4 GTPBP1 PPIA ZRANB1 RUFY3	2.53e-04	716	87	11	int:SNCA
Interaction	ADARB1 interactions	SCAF1 SF3B3 SNW1 AHNAK DDX51 NKTR HADHA APP PPIA	2.60e-04	489	87	9	int:ADARB1
Interaction	HACE1 interactions	NEK4 ZRANB1 PLXNA2	2.62e-04	29	87	3	int:HACE1
Interaction	MAG interactions	COL3A1 COL5A1 APP	2.62e-04	29	87	3	int:MAG
Interaction	CDC73 interactions	RAD51 RANBP2 SNW1 SUPT5H HADHA HSD17B4 ZRANB1 DNMT3B	2.63e-04	386	87	8	int:CDC73
Interaction	CTTNBP2NL interactions	NEK4 PPIA ZRANB1 RUFY3	2.66e-04	72	87	4	int:CTTNBP2NL
Interaction	NBPF14 interactions	NEK4 UBE3A	2.73e-04	6	87	2	int:NBPF14
Interaction	ADH4 interactions	APP ZRANB1	2.73e-04	6	87	2	int:ADH4
Interaction	UGT2A3 interactions	NEK4 ZRANB1	2.73e-04	6	87	2	int:UGT2A3
Interaction	SLC4A1AP interactions	SF3B3 ZCCHC8 APP PPIA ZRANB1	2.78e-04	133	87	5	int:SLC4A1AP
Interaction	TTC23 interactions	AHNAK APP HSD17B4 BHLHE40 ZRANB1 RUFY3	2.83e-04	208	87	6	int:TTC23
Interaction	LMNB1 interactions	RAD51 RANBP2 SF3B3 SNW1 SUPT5H DZIP3 RCC1 HERC2 PPIA ZRANB1	2.95e-04	610	87	10	int:LMNB1
Interaction	MAPT interactions	HSPA12A PDE2A MAP2 AHNAK SYTL2 HTATSF1 CASP8 HADHA APP GTPBP1 PPID ZRANB1 CD99L2 RUFY3	2.95e-04	1119	87	14	int:MAPT
Interaction	TRMT2A interactions	MELTF RCC1 HERC2 APP ZRANB1	3.41e-04	139	87	5	int:TRMT2A
Interaction	SIRT7 interactions	COL5A1 RANBP2 SNW1 ZCCHC8 SUPT5H AHNAK DDX51 HADHA HERC2 APP ZRANB1	3.51e-04	744	87	11	int:SIRT7
Interaction	PDGFA interactions	COL3A1 COL5A1 ZRANB1	3.52e-04	32	87	3	int:PDGFA
Interaction	KLHL29 interactions	DNAJB12 NPHP3 KLHL7	3.52e-04	32	87	3	int:KLHL29
Interaction	PLK1 interactions	RAD51 RANBP2 SF3B3 SNW1 DSC1 MYT1 APP PPID ZRANB1	3.54e-04	510	87	9	int:PLK1
Interaction	PRKAR2A interactions	HSPA12A MAP2 UBE3A APP PPIA ZRANB1	3.55e-04	217	87	6	int:PRKAR2A
Interaction	METTL13 interactions	EFNA2 SNW1 TMCO3 ZRANB1	3.62e-04	78	87	4	int:METTL13
Interaction	COL1A2 interactions	COL3A1 COL5A1 APP PPIA	3.62e-04	78	87	4	int:COL1A2
Interaction	COPS7B interactions	HSPA12A UBE3A APP PPIA ZRANB1	3.64e-04	141	87	5	int:COPS7B
Interaction	TUBA1A interactions	RAD51 NEK4 NCOA6 EFNA2 SF3B3 MAP2 ADAM7 HADHA HSD17B4 PPID ZRANB1	3.72e-04	749	87	11	int:TUBA1A
Interaction	SERBP1 interactions	NEK4 SCAF1 BPNT2 LPCAT1 SF3B3 DSC1 UBE3A HTATSF1 ANP32E RCC1 HADHA APP HSD17B4 GTPBP1 PPIA ZRANB1	3.74e-04	1432	87	16	int:SERBP1
Interaction	USP16 interactions	UBE3A HERC2 PPIA ZRANB1	3.80e-04	79	87	4	int:USP16
Interaction	IQCH interactions	NEK4 APP	3.81e-04	7	87	2	int:IQCH
Interaction	COPS6 interactions	HSPA12A SNX4 SNW1 UBE3A CASP8 APP ZRANB1 ZEB2	3.82e-04	408	87	8	int:COPS6
Interaction	SMC3 interactions	NEK4 MYOF SF3B3 SNW1 SUPT5H DZIP3 HERC2 ZRANB1	3.82e-04	408	87	8	int:SMC3
Interaction	IL24 interactions	RAD51 UBE3A CASP8	3.86e-04	33	87	3	int:IL24
Interaction	SF3B2 interactions	NEK4 RANBP2 SF3B3 SNW1 NEIL1 ZCCHC8 HTATSF1 APP ZRANB1	3.90e-04	517	87	9	int:SF3B2
Interaction	FHOD1 interactions	NCOA6 RANBP2 SNW1 PPIA	3.99e-04	80	87	4	int:FHOD1
Interaction	EMC2 interactions	MYOF RANBP2 SF3B3 SUPT5H AHNAK HADHA HSD17B4 ZRANB1	4.01e-04	411	87	8	int:EMC2
Interaction	PTPN2 interactions	COL5A1 UBE3A ANP32E HADHA APP ZRANB1	4.11e-04	223	87	6	int:PTPN2
Interaction	MSH2 interactions	RAD51 SNW1 SUPT5H DZIP3 RCC1 PPIA ZRANB1	4.12e-04	313	87	7	int:MSH2
Interaction	RANGAP1 interactions	NCOA6 RANBP2 NRXN3 SNW1 SUPT5H RCC1 ZRANB1	4.20e-04	314	87	7	int:RANGAP1
Interaction	ERCC6 interactions	NEK4 SF3B3 HTATSF1 RCC1 PPIA ZRANB1	4.21e-04	224	87	6	int:ERCC6
Interaction	TCEANC2 interactions	HTATSF1 APP ZRANB1	4.22e-04	34	87	3	int:TCEANC2
Interaction	PLEKHJ1 interactions	SUPT5H APP DNMT3B	4.22e-04	34	87	3	int:PLEKHJ1
Interaction	CCNT1 interactions	SNW1 SUPT5H HTATSF1 HIC2 KDM1B ZRANB1	4.31e-04	225	87	6	int:CCNT1
Interaction	EMC1 interactions	DNAJB12 MYOF RANBP2 MELTF PDE2A SUPT5H AHNAK ZRANB1	4.48e-04	418	87	8	int:EMC1
Interaction	WAC interactions	SYTL5 SUPT5H APP ZRANB1	4.59e-04	83	87	4	int:WAC
Interaction	STEEP1 interactions	SNW1 APP PPIA ZRANB1	4.59e-04	83	87	4	int:STEEP1
Interaction	UCHL5 interactions	SNW1 DSC1 UBE3A ANP32E HERC2 APP ZRANB1	4.61e-04	319	87	7	int:UCHL5
Interaction	RBM4 interactions	NEK4 SCAF1 SNW1 DDX51 PPIA ZRANB1 LRP2BP	4.61e-04	319	87	7	int:RBM4
Interaction	H2AC20 interactions	NEK4 MELTF NEIL1 RCC1 APP ZRANB1 CD99L2	4.70e-04	320	87	7	int:H2AC20
Interaction	U2AF2 interactions	SCAF1 SF3B3 SNW1 NEIL1 ZCCHC8 AHNAK NKTR HERC2 PPIA ZRANB1	4.93e-04	651	87	10	int:U2AF2
Interaction	HSDL2 interactions	HADHA HERC2 HSD17B4 PPIA ZRANB1	4.98e-04	151	87	5	int:HSDL2
Interaction	TOP3B interactions	RAD51 SCAF1 MYOF NCOA6 PDE2A EFNA2 AHNAK RCC1 HADHA HERC2 APP GTPBP1 ATP2A3 CABLES1 AGAP3 ITPR2	4.99e-04	1470	87	16	int:TOP3B
Interaction	RAD51AP1 interactions	RAD51 APP ZRANB1	5.01e-04	36	87	3	int:RAD51AP1
Interaction	ARHGEF5 interactions	SF3B3 HERC2 APP ZRANB1	5.03e-04	85	87	4	int:ARHGEF5
Interaction	REG1A interactions	NEK4 APP	5.07e-04	8	87	2	int:REG1A
GeneFamily	Cyclophilin peptidylprolyl isomerases	RANBP2 NKTR PPIA PPID	5.66e-07	19	65	4	909
GeneFamily	Synaptotagmin like tandem C2 proteins	SYTL5 SYTL2	5.62e-04	10	65	2	822
GeneFamily	Collagens	COL3A1 COL5A1 COL19A1	6.03e-04	46	65	3	490
GeneFamily	DNA glycosylases	NEIL1 NTHL1	6.85e-04	11	65	2	1024
GeneFamily	CD molecules\|Type II classical cadherins	CDH22 CDH12	9.68e-04	13	65	2	1186
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	SUSD5 CSMD1 CSMD2	1.13e-03	57	65	3	1179
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RANBP2 ZRANB1	2.56e-03	21	65	2	89
Coexpression	GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP	SLC8A3 SGPL1 HIC2 RCC1 DDX51 PPIA DNMT3B AGAP3	3.23e-07	198	87	8	M7837
Coexpression	ESC_V6.5_UP_EARLY.V1_DN	COL3A1 SLC8A3 AHNAK APP BHLHE40 PCOLCE	1.76e-05	163	87	6	M2769
Coexpression	GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN	PDE2A AHNAK SYTL2 ATP6V0D2 BHLHE40 ZEB2	3.07e-05	180	87	6	M6317
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL	COL3A1 COL5A1 HSPA12A NRXN3 COL19A1 AHNAK BHLHE40	3.14e-05	268	87	7	M45796
Coexpression	FARMER_BREAST_CANCER_CLUSTER_4	COL3A1 COL5A1 PCOLCE	3.29e-05	19	87	3	M15125
Coexpression	GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN	MYOF UBE3A SUPT5H CASP8 BHLHE40 PCOLCE	5.53e-05	200	87	6	M4878
Coexpression	GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP	BPNT2 SNW1 NEIL1 AHNAK SYTL2 ATP6V0D2	5.53e-05	200	87	6	M6549
Coexpression	GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN	COL5A1 AHNAK CASP8 DDX51 PPID BHLHE40	5.53e-05	200	87	6	M8524
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RAD51 ANP32E PPIA PPID ZEB2 PCOLCE	1.60e-06	183	87	6	523896bd1a93bdda81a009768baa3a1bdbd108b8
ToppCell	Substantia_nigra-Endothelial\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	COL3A1 MYOF AHNAK DDR2 CASP8 PCOLCE	1.93e-06	189	87	6	bef8234bd9c4d6e3cdef0791d8066b39ba56ebba
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 NRXN3 MAP2 DDR2 PCOLCE	2.25e-06	194	87	6	415801a3dfacf05f2b603fb424df3d045190a812
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 NRXN3 MAP2 DDR2 PCOLCE	2.25e-06	194	87	6	256cb33ec90328f2704921fb0fe0fd9812e138b0
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 NRXN3 MAP2 DDR2 PCOLCE	2.25e-06	194	87	6	7942bc83c1bdca687795b91aa232824d603f9b09
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL3A1 NRXN3 SGPL1 DDR2 ZEB2 PLXNA2	2.31e-06	195	87	6	b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL3A1 NRXN3 SGPL1 DDR2 ZEB2 PLXNA2	2.31e-06	195	87	6	a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL3A1 COL5A1 AHNAK APP ZEB2 PCOLCE	2.46e-06	197	87	6	6668f0da54f3bf96769275e668cd57e00b8a5ef9
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL3A1 COL5A1 AHNAK APP ZEB2 PCOLCE	2.46e-06	197	87	6	7c275a2ac24a9a4f83fceda93a067e754837102f
ToppCell	5'-GW_trimst-2\|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL3A1 COL5A1 MELTF BHLHE40 ZEB2 PCOLCE	2.53e-06	198	87	6	677816ea6d1706d99b7757d43b6b375276b25639
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL3A1 COL5A1 HSPA12A DDR2 ZEB2 PCOLCE	2.60e-06	199	87	6	36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL3A1 COL5A1 MYOF DDR2 SYTL2 PCOLCE	2.60e-06	199	87	6	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL3A1 COL5A1 MYOF DDR2 ZEB2 PCOLCE	2.60e-06	199	87	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL3A1 COL5A1 MYOF DDR2 SYTL2 ZEB2	2.60e-06	199	87	6	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	Brain_organoid-organoid_Tanaka_cellReport\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	COL3A1 COL5A1 MYOF AHNAK DDR2 PCOLCE	2.68e-06	200	87	6	b0ba486b55be18a4236bd2644f02352651f4b1fe
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL3A1 COL5A1 HSPA12A DDR2 ZEB2 PCOLCE	2.68e-06	200	87	6	3dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL3A1 COL5A1 MYOF DDR2 ZEB2 PCOLCE	2.68e-06	200	87	6	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL3A1 COL5A1 MYOF DDR2 ZEB2 PCOLCE	2.68e-06	200	87	6	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL3A1 COL5A1 HSPA12A DDR2 ZEB2 PCOLCE	2.68e-06	200	87	6	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL3A1 COL5A1 DDR2 SYTL2 ZEB2 PCOLCE	2.68e-06	200	87	6	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUSD5 ADAM7 MYT1 ATP6V0D2 CDH12	1.66e-05	162	87	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	control-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HSPA12A ATP6V0D2 CSMD2 ATP2A3 ITPR2	1.97e-05	168	87	5	327b02f19f4a8607c033203824fdc60a1254331f
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A MYT1 CSMD1 ATP2A3 ITPR2	2.03e-05	169	87	5	05e12524d68d409fed386ffad233305683b4575b
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|normal_Lymph_Node / Location, Cell class and cell subclass	RANBP2 MELTF ZCCHC8 APP ZEB2	2.47e-05	176	87	5	476794ef75ce5ab732d78cfeb4944e2f841e3e92
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 MYOF EFNA2 MAP2	2.47e-05	176	87	5	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 MYOF EFNA2 MAP2	2.47e-05	176	87	5	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDH22 DSC1 ATP6V0D2 CSMD2 ITPR2	2.82e-05	181	87	5	40df0afcb6848202da54670e84f22d7c3a515d01
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDH22 DSC1 ATP6V0D2 CSMD2 ITPR2	2.82e-05	181	87	5	2b53a65ca5616a7b9f64232c3e0b7212d1e2f063
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDH22 DSC1 ATP6V0D2 CSMD2 ITPR2	2.82e-05	181	87	5	6aef84616e8d2faf54b7e9e6cd02f33c3066dabc
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDH22 DSC1 ATP6V0D2 CSMD2 ITPR2	2.82e-05	181	87	5	40d3829ae4aaf81e8616c3499ff8933137fc1cc4
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	2.90e-05	182	87	5	b7d532feb73167e05475855061b35a209583f44c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	2.90e-05	182	87	5	af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOF PDE2A SYTL5 SYTL2 ATP2A3	2.97e-05	183	87	5	5a936fb07074cec753bf19e3e3e52499605ea22c
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL3A1 COL5A1 HSPA12A DDR2 PCOLCE	2.97e-05	183	87	5	06a68fa2be36448064f4668be24a5b85ad85c6e8
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RAD51 NTHL1 DDR2 PRDM15 CABLES1	2.97e-05	183	87	5	dd15e1463a0d57d14800de0df0645c81c56926ae
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RAD51 NTHL1 DDR2 PRDM15 CABLES1	2.97e-05	183	87	5	8ace19c38b89556d2504258a63aa5a2b14f5cd36
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOF PDE2A SYTL5 SYTL2 ATP2A3	2.97e-05	183	87	5	07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 DDR2 NIM1K ZEB2	3.05e-05	184	87	5	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	LPCAT1 AHNAK SYTL2 BHLHE40 ZEB2	3.05e-05	184	87	5	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.13e-05	185	87	5	3cd0686a14e734a0f243070ab939adcb4c454478
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.13e-05	185	87	5	00258f458cbf6d36449db95528a6b5038d731d2d
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.13e-05	185	87	5	a94694e226856bc5b168464f52d76004145717a5
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 MAP2 DDR2 PCOLCE	3.13e-05	185	87	5	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 MAP2 DDR2 PCOLCE	3.13e-05	185	87	5	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 MAP2 DDR2 PCOLCE	3.13e-05	185	87	5	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 SLC8A3 DDR2 CSMD1	3.21e-05	186	87	5	94d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	COL3A1 COL5A1 MYOF MAP2 ZEB2	3.21e-05	186	87	5	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL3A1 COL5A1 DDR2 SYTL2 PCOLCE	3.21e-05	186	87	5	827f2f2ddde315d1e5970dd56f906c555ec699af
ToppCell	Frontal_cortex-Endothelial\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	COL3A1 MYOF AHNAK DDR2 PCOLCE	3.38e-05	188	87	5	a43392dbd10fc7dbfb31be39b8af8a7ea121c894
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.38e-05	188	87	5	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	SCAF1 LPCAT1 AHNAK SYTL2 ZEB2	3.47e-05	189	87	5	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	SCAF1 LPCAT1 AHNAK SYTL2 ZEB2	3.47e-05	189	87	5	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL3A1 COL5A1 MYOF DDR2 PCOLCE	3.47e-05	189	87	5	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	MatrixFB-Fibroblast-C\|MatrixFB / shred on cell class and cell subclass (v4)	COL3A1 COL5A1 AHNAK APP PCOLCE	3.56e-05	190	87	5	d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.56e-05	190	87	5	bd0d68dc1b6f388190a6ba8a83b011619abe2bdd
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.56e-05	190	87	5	e275de94468872e70cf305b3b450823d4c9c5e3f
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.56e-05	190	87	5	ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL3A1 COL5A1 SLC8A3 DDR2 PCOLCE	3.56e-05	190	87	5	cf463b2f227f3cc7d3fd296c810c0cbe51cbee72
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 SUSD5 DDR2 ZEB2	3.56e-05	190	87	5	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	Myeloid-Myeloid-B_(Activated_Macrophage)\|Myeloid / shred on cell class and cell subclass (v4)	MYOF RANBP2 ATP6V0D2 APP ITPR2	3.65e-05	191	87	5	7bf125249af1e8bb138ed4d999fdd74b03ab2447
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 MAP2 DDR2 PCOLCE	3.65e-05	191	87	5	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3\|TCGA-Ovary / Sample_Type by Project: Shred V9	COL3A1 COL5A1 MYOF BHLHE40 ZEB2	3.65e-05	191	87	5	80d30d8eedb4c70b58440646325bc04c5700803e
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	COL3A1 COL5A1 MYOF MAP2 ZEB2	3.65e-05	191	87	5	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL3A1 COL5A1 MYOF DDR2 SYTL2	3.74e-05	192	87	5	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL3A1 COL5A1 DDR2 CSMD2 PCOLCE	3.74e-05	192	87	5	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL3A1 SUSD5 DDR2 SYTL2 ZEB2	3.74e-05	192	87	5	992d08092edbc68c47b945deb8708379738c239a
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 APP PCOLCE	3.74e-05	192	87	5	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL3A1 COL5A1 MYOF DDR2 PCOLCE	3.74e-05	192	87	5	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL3A1 COL5A1 MYOF DDR2 PCOLCE	3.74e-05	192	87	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A ABCB9 SYTL2 TMCO3 ATP2A3	3.83e-05	193	87	5	6a9bce5064938b5b84ad57b4fd4a7841afe100c8
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A SYTL2 TMCO3 ATP2A3 BHLHE40	3.83e-05	193	87	5	4aee372ba2c0351b0221d0d468707d1ad21526d6
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A SYTL2 TMCO3 ATP2A3 BHLHE40	3.83e-05	193	87	5	aaa5042388dc451bff384c6bb237348f08280a08
ToppCell	droplet-Heart-nan-3m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.93e-05	194	87	5	ce32e60bcea1b8baf496ce9050832bc8c77d8434
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	COL3A1 SUSD5 DDR2 ZEB2 PCOLCE	3.93e-05	194	87	5	2260cd817a6661e5eb6645b0c6786e18fd58371e
ToppCell	droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 SYTL2 PCOLCE	3.93e-05	194	87	5	775600880bb77781de48085d8744c1030223de1f
ToppCell	droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.93e-05	194	87	5	a1dc157148885cc8d3685ac81a1f4e3562aeecc9
ToppCell	droplet-Heart-nan-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.93e-05	194	87	5	20a0439fa02c5f8107612e34c7ab54120b9b8573
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	LPCAT1 AHNAK SYTL2 BHLHE40 ZEB2	3.93e-05	194	87	5	ecdfc27d06e363fb23f0309f26ef6404a89f14ec
ToppCell	droplet-Pancreas-Exocrine-21m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 SYTL2 PCOLCE	3.93e-05	194	87	5	04ecb609d233a4b12e275c604810937830363e17
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	3.93e-05	194	87	5	8c37bedb23285735ff3828db3889897fada8c95d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL3A1 COL5A1 MYOF DDR2 PCOLCE	3.93e-05	194	87	5	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL3A1 COL5A1 MYOF DDR2 PCOLCE	3.93e-05	194	87	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 MAP2 DDR2 ZEB2	3.93e-05	194	87	5	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL3A1 COL5A1 MYOF AHNAK PCOLCE	4.02e-05	195	87	5	78cfde21dde4b877fc76c8b0d5ddaabe44b912d7
ToppCell	P07-Mesenchymal\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.02e-05	195	87	5	859764b605866b6c3e6edd0698670ca9c0f20745
ToppCell	droplet-Heart-nan-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.02e-05	195	87	5	613bea20c3d82c22a6af4c1a668af6fcf11fec0a
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.02e-05	195	87	5	223f5f07dc28fa13a09bb589884c58043c7928c7
ToppCell	droplet-Heart-nan-18m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.02e-05	195	87	5	9ffabd831c2a0de3597f328e83db7ee259cb0ccc
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL3A1 COL5A1 MELTF DDR2 PCOLCE	4.02e-05	195	87	5	0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL3A1 COL5A1 MELTF DDR2 PCOLCE	4.02e-05	195	87	5	2a6f67875cef140b0e6b8401436719675c6b3665
ToppCell	Mesenchymal_cells\|World / Lineage and Cell class	COL3A1 AHNAK DDR2 BHLHE40 PCOLCE	4.02e-05	195	87	5	380eb436baa371f7aa2dc0c4a594afb173b5a25b
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.12e-05	196	87	5	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL5A1 MAP2 SUSD5 ZEB2	4.12e-05	196	87	5	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL3A1 COL5A1 NRXN3 DDR2 ZEB2	4.12e-05	196	87	5	acbb493dbb49a33f20cf11106363f7ed51209706
ToppCell	PCW_07-8.5-Mesenchymal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.12e-05	196	87	5	8e10802f52e5e1853ea4ad34bf9a32a34e6112b5
ToppCell	facs-Trachea\|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL3A1 COL5A1 DDR2 BHLHE40 PCOLCE	4.12e-05	196	87	5	8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.12e-05	196	87	5	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	facs-Trachea\|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 DDR2 BHLHE40 PCOLCE	4.12e-05	196	87	5	34020d6553309daa269dff05de0a8567211ea4d2
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL5A1 MYOF DDR2 PCOLCE	4.12e-05	196	87	5	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	PND07-Mesenchymal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL3A1 COL5A1 DDR2 ZEB2 PCOLCE	4.12e-05	196	87	5	0050c7134473fbfd7b9f0ae8d6d337713e60b57d
Drug	Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	COL5A1 YIPF2 DZIP3 CASP8 HIC2 RCC1 RUFY3 ITPR2	8.22e-07	195	87	8	5388_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	DNAJB12 COL5A1 MYOF ZNF609 ABCB9 RCC1 ITPR2	8.99e-06	192	87	7	3753_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	IQSEC2 HTATSF1 HIC2 RCC1 APP ATP2A3 BHLHE40	9.30e-06	193	87	7	3841_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ZNF609 ABCB9 AHNAK DDR2 APP ATP2A3 BHLHE40	1.03e-05	196	87	7	5397_UP
Drug	Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; PC3; HG-U133A	MYOF BPNT2 SNW1 RCC1 NKTR APP BHLHE40	1.10e-05	198	87	7	1940_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A	ZNF609 COL19A1 AHNAK SYTL2 NKTR APP ITPR2	1.10e-05	198	87	7	2197_UP
Drug	Gliquidone [33342-05-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	DNAJB12 MYOF MAP2 NEIL1 ADAM7 DDX51 ATP2A3	1.13e-05	199	87	7	6004_UP
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A	YIPF2 ZNF609 DZIP3 CASP8 NKTR APP RUFY3	1.13e-05	199	87	7	5788_DN
Drug	Cytarabine	RAD51 COL3A1 COL5A1 MYOF BPNT2 MAP2 AHNAK DDR2 SYTL2 CASP8 GTPBP1	1.72e-05	598	87	11	ctd:D003561
Drug	2-deoxyribose 5-phosphate	RAD51 NEIL1 NTHL1	4.22e-05	18	87	3	CID000150629
Drug	17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A	RAD51 DNAJB12 IQSEC2 APP PPID DNMT3B	7.31e-05	183	87	6	1154_UP
Drug	Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A	COL5A1 MYOF YIPF2 ABCB9 HIC2 ITPR2	9.00e-05	190	87	6	3468_UP
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MYOF ZNF609 CASP8 HIC2 APP RUFY3	9.00e-05	190	87	6	3927_DN
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A	COL3A1 ABCB9 UBE3A SUSD5 AHNAK RUFY3	9.26e-05	191	87	6	4580_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	COL3A1 COL5A1 YIPF2 MELTF AHNAK BHLHE40	9.53e-05	192	87	6	5930_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A	HSPA12A ABCB9 DZIP3 CASP8 RCC1 RUFY3	9.80e-05	193	87	6	1464_DN
Drug	Hycanthone [3105-97-3]; Down 200; 11.2uM; PC3; HT_HG-U133A	COL5A1 MYOF ZNF609 SYTL2 DZIP3 ITPR2	9.80e-05	193	87	6	4630_DN
Drug	ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A	YIPF2 NRXN3 APP ATP2A3 PLXNA2 ITPR2	9.80e-05	193	87	6	7490_UP
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A	DNAJB12 ABCB9 AHNAK HIC2 DDX51 ITPR2	9.80e-05	193	87	6	6678_UP
Drug	Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A	DNAJB12 MYOF ZNF609 ABCB9 APP ATP2A3	1.01e-04	194	87	6	4838_UP
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; HL60; HT_HG-U133A	SF3B3 DZIP3 HTATSF1 RCC1 APP RUFY3	1.04e-04	195	87	6	1866_DN
Drug	CP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A	COL3A1 ZNF609 HIC2 RCC1 NKTR ATP2A3	1.04e-04	195	87	6	4382_UP
Drug	Fluorometholone [426-13-1]; Down 200; 10.6uM; HL60; HT_HG-U133A	RAD51 MYOF ZNF609 SGPL1 MYT1 DNMT3B	1.04e-04	195	87	6	2509_DN
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; HL60; HT_HG-U133A	ZNF609 DZIP3 CASP8 RCC1 TMCO3 APP	1.04e-04	195	87	6	2173_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	DNAJB12 MYOF SGPL1 ATP2A3 BHLHE40 RUFY3	1.04e-04	195	87	6	3923_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	DNAJB12 YIPF2 ZNF609 MYT1 APP ATP2A3	1.07e-04	196	87	6	1323_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A	DNAJB12 MYOF ABCB9 UBE3A ATP2A3 BHLHE40	1.07e-04	196	87	6	3263_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	RAD51 DNAJB12 COL5A1 ABCB9 ATP2A3 RUFY3	1.07e-04	196	87	6	5604_DN
Drug	Gramine [87-52-5]; Up 200; 23uM; PC3; HT_HG-U133A	DNAJB12 NRXN3 DZIP3 HIC2 ATP2A3 RUFY3	1.07e-04	196	87	6	3999_UP
Drug	Indapamide [26807-65-8]; Up 200; 10.6uM; PC3; HT_HG-U133A	DNAJB12 PDE2A IQSEC2 HIC2 RCC1 DDX51	1.07e-04	196	87	6	4335_UP
Drug	Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	RAD51 MYOF YIPF2 MELTF SGPL1 ATP2A3	1.07e-04	196	87	6	3461_UP
Drug	Aminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A	COL5A1 ZNF609 HIC2 APP RUFY3 ITPR2	1.07e-04	196	87	6	5394_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; PC3; HT_HG-U133A	MELTF DSC1 UBE3A AHNAK IQSEC2 ATP2A3	1.07e-04	196	87	6	6740_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	COL5A1 MYOF YIPF2 ZNF609 HIC2 APP	1.07e-04	196	87	6	5409_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	COL5A1 ZNF609 CASP8 HIC2 RCC1 RUFY3	1.07e-04	196	87	6	5386_DN
Drug	Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A	ZNF609 DZIP3 OGFOD1 CASP8 TMCO3 RUFY3	1.07e-04	196	87	6	7408_UP
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	DNAJB12 COL5A1 SUPT5H APP GTPBP1 RUFY3	1.10e-04	197	87	6	1795_DN
Drug	Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A	COL5A1 SUSD5 HIC2 GTPBP1 RUFY3 ITPR2	1.10e-04	197	87	6	3048_UP
Drug	Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; PC3; HT_HG-U133A	DNAJB12 PDE2A ZNF609 ABCB9 PLXNA2 ITPR2	1.10e-04	197	87	6	5796_UP
Drug	Triflusal [322-79-2]; Up 200; 16.2uM; HL60; HG-U133A	BPNT2 NTHL1 MYT1 CASP8 GTPBP1 DNMT3B	1.10e-04	197	87	6	1717_UP
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA	COL5A1 MYOF SGPL1 SYTL2 RCC1 RUFY3	1.10e-04	197	87	6	1042_UP
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; HL60; HG-U133A	MYOF RANBP2 UBE3A SGPL1 AHNAK BHLHE40	1.10e-04	197	87	6	2012_DN
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A	YIPF2 AHNAK IQSEC2 DZIP3 CASP8 RCC1	1.10e-04	197	87	6	3769_DN
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	ZNF609 DSC1 ABCB9 IQSEC2 RCC1 ATP2A3	1.10e-04	197	87	6	2103_UP
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; PC3; HT_HG-U133A	RAD51 DNAJB12 PDE2A ABCB9 HIC2 APP	1.13e-04	198	87	6	3721_UP
Drug	Milrinone [78415-72-2]; Up 200; 19uM; PC3; HT_HG-U133A	COL3A1 NRXN3 DZIP3 HIC2 RCC1 ITPR2	1.13e-04	198	87	6	5856_UP
Drug	5149715; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ZNF609 SGPL1 HTATSF1 RCC1 NKTR RUFY3	1.13e-04	198	87	6	890_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; HL60; HT_HG-U133A	YIPF2 SUPT5H NKTR APP RUFY3 ITPR2	1.13e-04	198	87	6	1300_UP
Drug	(-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; MCF7; HT_HG-U133A	COL3A1 COL5A1 ABCB9 NEIL1 KIAA0232 CASP8	1.13e-04	198	87	6	2772_UP
Drug	Sulfadiazine [68-35-9]; Up 200; 16uM; MCF7; HT_HG-U133A	RAD51 MYOF ABCB9 CASP8 NKTR RUFY3	1.13e-04	198	87	6	1688_UP
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	MELTF PDE2A NRXN3 NEIL1 APP ITPR2	1.13e-04	198	87	6	4102_UP
Drug	Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; PC3; HT_HG-U133A	COL3A1 ZNF609 NRXN3 DZIP3 APP RUFY3	1.13e-04	198	87	6	7273_UP
Drug	Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	MYOF ZNF609 ABCB9 KIAA0232 AHNAK BHLHE40	1.13e-04	198	87	6	3270_UP
Drug	Benperidol [2062-84-2]; Up 200; 10.4uM; PC3; HT_HG-U133A	DNAJB12 SUSD5 AHNAK CASP8 RUFY3 ITPR2	1.13e-04	198	87	6	4196_UP
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A	COL5A1 SGPL1 DZIP3 RCC1 TMCO3 RUFY3	1.16e-04	199	87	6	6491_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	COL5A1 MYOF IQSEC2 HIC2 TMCO3 ATP2A3	1.16e-04	199	87	6	6256_UP
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A	DNAJB12 YIPF2 HSPA12A AHNAK IQSEC2 HIC2	1.19e-04	200	87	6	5735_UP
Drug	Ginkgolide A [15291-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A	YIPF2 MELTF DSC1 SUSD5 CASP8 ITPR2	1.19e-04	200	87	6	4002_UP
Drug	Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A	DNAJB12 ADAM7 CASP8 DDX51 APP PLXNA2	1.19e-04	200	87	6	5991_UP
Drug	1,2-cyclopentanedione	NEIL1 NTHL1	1.43e-04	5	87	2	CID000566657
Drug	BPAT-143	COL3A1 COL5A1	2.14e-04	6	87	2	CID000146249
Drug	AC1L18GG	HADHA HSD17B4	2.14e-04	6	87	2	CID000000090
Drug	Tw 26	NEIL1 NTHL1	2.14e-04	6	87	2	CID000164868
Drug	poly(ethylene-co-propylene	APP CABLES1	2.14e-04	6	87	2	CID000062702
Drug	fenoxaprop	APP CDH12	2.99e-04	7	87	2	CID000086134
Drug	9-aminoellipticine	NEIL1 NTHL1	2.99e-04	7	87	2	CID000099172
Drug	[R,S]-Lactyl CoA	HADHA HSD17B4	2.99e-04	7	87	2	CID000440609
Drug	AC1L99M6	HADHA HSD17B4	2.99e-04	7	87	2	CID000440603
Drug	AC1L99MC	HADHA HSD17B4	2.99e-04	7	87	2	CID000440605
Drug	AC1L99MI	HADHA HSD17B4	2.99e-04	7	87	2	CID000440607
Drug	SureCN1046598	EFNA2 APP	2.99e-04	7	87	2	CID011655188
Drug	Betaine	MYOF ANP32E APP BHLHE40 DNMT3B	3.43e-04	157	87	5	ctd:D001622
Drug	testosterone enanthate	COL3A1 COL5A1 RANBP2 HTATSF1 NKTR HADHA APP HSD17B4 RUFY3	3.50e-04	575	87	9	ctd:C004648
Drug	AC1L99M3	HADHA HSD17B4	3.98e-04	8	87	2	CID000440602
Drug	Ga14	RAD51 CASP8 APP	4.13e-04	38	87	3	CID000443451
Drug	AC1L9HPX	COL3A1 COL5A1 PPIA PPID	4.30e-04	92	87	4	CID000445279
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	DNAJB12 ZNF609 UBE3A SGPL1 RUFY3	4.31e-04	165	87	5	6085_DN
Drug	SAHA; Up 200; 10uM; PC3; HT_HG-U133A	NRXN3 ABCB9 MAP2 SYTL2 DNMT3B	4.31e-04	165	87	5	4444_UP
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	DNAJB12 SGPL1 APP ATP2A3 PPID	4.93e-04	170	87	5	1167_UP
Drug	Meta Vanadate	RAD51 CABLES1	5.11e-04	9	87	2	CID000445092
Drug	3-oxo-octanoyl-coenzyme A	HADHA HSD17B4	5.11e-04	9	87	2	CID000440608
Drug	AC1L99M9	HADHA HSD17B4	5.11e-04	9	87	2	CID000440604
Drug	AC1L99MF	HADHA HSD17B4	5.11e-04	9	87	2	CID000440606
Drug	K00271	MYT1 HSD17B4	5.11e-04	9	87	2	CID005486761
Drug	arsenals	RAD51 UBE3A HERC2	5.17e-04	41	87	3	CID000062286
Drug	deoxyribose 5-phosphate	NEIL1 SGPL1 NTHL1	5.17e-04	41	87	3	CID000000635
Drug	hydroxystearic acid	NEIL1 SUPT5H HERC2	5.55e-04	42	87	3	CID000007789
Drug	Digitoxigenin [143-62-4]; Up 200; 10.6uM; PC3; HT_HG-U133A	DNAJB12 MELTF ZNF609 DSC1 HIC2	6.23e-04	179	87	5	4217_UP
Drug	Fluorouracil	COL3A1 NEK4 MYOF SF3B3 MAP2 KLHL7 AHNAK SYTL2 CASP8 ANP32E HIC2 RCC1 DNMT3B AGAP3	6.35e-04	1364	87	14	ctd:D005472
Drug	5-formyl-2'-deoxyuridine	RAD51 NTHL1	6.37e-04	10	87	2	CID000098561
Drug	Meala-csa	PPIA PPID	6.37e-04	10	87	2	CID006436248
Drug	cortisone	RAD51 NPHP3 NTHL1 PPIA	6.59e-04	103	87	4	CID000222786
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	DNAJB12 MYOF ZNF609 RCC1 RUFY3	6.72e-04	182	87	5	5802_DN
Drug	5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA	MYOF SYTL2 HIC2 RCC1 BHLHE40	7.24e-04	185	87	5	944_UP
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	SGPL1 IQSEC2 APP GTPBP1 PPID	7.59e-04	187	87	5	1147_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZNF609 SYTL2 HIC2 RCC1 RUFY3	7.59e-04	187	87	5	1631_DN
Drug	Furan	RAD51 NEIL1 NTHL1	7.74e-04	47	87	3	CID000008029
Drug	tetradecanedioate	HADHA HSD17B4	7.76e-04	11	87	2	CID000013185
Drug	Prodigiosin	RAD51 CASP8	7.76e-04	11	87	2	ctd:D011353
Drug	oh5dU	NEIL1 NTHL1	7.76e-04	11	87	2	CID000096622
Disease	Ischemic stroke	COL3A1 APP	4.67e-05	4	83	2	C0948008
Disease	X-11423--O-sulfo-L-tyrosine measurement	MYT1 PLXNA2	1.16e-04	6	83	2	EFO_0021231
Disease	coronary aneurysm	NRXN3 CSMD1 CSMD2	1.32e-04	35	83	3	EFO_1000881
Disease	Autoimmune Lymphoproliferative Syndrome Type 2B	COL5A1 CASP8	1.63e-04	7	83	2	C1846545
Disease	suntan	NCOA6 HERC2 PRDM15 DNMT3B	2.08e-04	103	83	4	EFO_0004279
Disease	postherpetic neuralgia	NRXN3 CABLES1	2.16e-04	8	83	2	MONDO_0041052
Disease	Ehlers-Danlos syndrome	COL3A1 COL5A1	2.16e-04	8	83	2	cv:C0013720
Disease	Ehlers-Danlos syndrome (is_implicated_in)	COL3A1 COL5A1	2.78e-04	9	83	2	DOID:13359 (is_implicated_in)
Disease	Brain hemorrhage	COL3A1 APP	3.47e-04	10	83	2	C0553692
Disease	obesity (implicated_via_orthology)	NEIL1 SGPL1 HSD17B4 HSDL1 ITPR2	3.59e-04	215	83	5	DOID:9970 (implicated_via_orthology)
Disease	Bipolar Disorder	NEK4 MAP2 CASP8 CSMD1 APP PPID BHLHE40	3.98e-04	477	83	7	C0005586
Disease	rheumatic heart disease (biomarker_via_orthology)	COL3A1 ZEB2	5.07e-04	12	83	2	DOID:0050827 (biomarker_via_orthology)
Disease	adiponectin measurement	COL3A1 NRXN3 ABCB9 HERC2	7.81e-04	146	83	4	EFO_0004502
Disease	lipid metabolism disorder (implicated_via_orthology)	HADHA HSD17B4	8.02e-04	15	83	2	DOID:3146 (implicated_via_orthology)
Disease	Colorectal Carcinoma	COL3A1 CDH22 MAP2 NTHL1 FRMPD2 CASP8 ZEB2 CABLES1	8.10e-04	702	83	8	C0009402
Disease	Schizophrenia	COL3A1 HSPA12A NRXN3 CSMD1 CSMD2 PPIA BHLHE40 PLXNA2 DNMT3B	8.40e-04	883	83	9	C0036341
Disease	Malignant neoplasm of breast	RAD51 NCOA6 PDE2A SLC8A3 COL19A1 CASP8 HERC2 ATP2A3 ZEB2 DNMT3B	8.58e-04	1074	83	10	C0006142
Disease	breast cancer (is_implicated_in)	RAD51 NCOA6 SNW1 CASP8	8.63e-04	150	83	4	DOID:1612 (is_implicated_in)
Disease	Schizoaffective disorder-bipolar type	NRXN3 MYT1	9.14e-04	16	83	2	EFO_0009965
Disease	non-melanoma skin carcinoma	NCOA6 CASP8 HERC2 CSMD2 DNMT3B	9.23e-04	265	83	5	EFO_0009260
Disease	anorectal malformation	SUSD5 CSMD2	1.30e-03	19	83	2	MONDO_0019938
Disease	mucocutaneous lymph node syndrome	COL3A1 CDH22 PLXNA2	1.30e-03	76	83	3	EFO_0004246
Disease	Headache, HbA1c measurement	DDR2 CASP8	1.59e-03	21	83	2	EFO_0004541, HP_0002315
Disease	BREAST CANCER	RAD51 CASP8	1.59e-03	21	83	2	114480
Disease	lung cancer	CSMD1 ZRANB1	1.59e-03	21	83	2	MONDO_0008903
Disease	JT interval, response to sulfonylurea	NRXN3 HSD17B4	1.90e-03	23	83	2	EFO_0007885, EFO_0007922
Disease	nighttime rest measurement	RCC1 CSMD1	2.07e-03	24	83	2	EFO_0007827
Disease	airway responsiveness measurement	DZIP3 CSMD1	2.07e-03	24	83	2	EFO_0006897
Disease	Endogenous Hyperinsulinism	COL3A1 NEIL1	2.43e-03	26	83	2	C1257963
Disease	Exogenous Hyperinsulinism	COL3A1 NEIL1	2.43e-03	26	83	2	C1257964
Disease	Compensatory Hyperinsulinemia	COL3A1 NEIL1	2.43e-03	26	83	2	C1257965
Disease	Malignant tumor of breast	RAD51 CASP8	2.62e-03	27	83	2	cv:C0006142
Disease	Breast neoplasm	RAD51 CASP8	2.62e-03	27	83	2	cv:C1458155
Disease	Familial cancer of breast	RAD51 CASP8	2.62e-03	27	83	2	cv:C0346153

Protein segments in the cluster

Peptide	Gene	Start	Entry
RGYGKSEGEASEEGL	ABHD13	151	Q7L211
HGSKEEVNETYGDGD	AGAP3	771	Q96P47
RGYDTLTVGDAGKVG	CSMD1	461	Q96PZ7
GYDTLTVGDGGQDGD	CSMD2	456	Q7Z408
DGDSSEYQDGKEFGI	DNMT3B	211	Q9UBC3
GGADTDYADGSEDKV	APP	211	P05067
TETLGVENKGYFGDE	ADAM7	706	Q9H2U9
TDSGYGGESEKGDLR	BHLHE40	241	O14503
VIGQGSDGTEYGLSE	GTPBP1	96	O00178
YEVTGSDDETGKLQG	AHNAK	5836	Q09666
GSELGEGEEEVGLSY	ANP32E	206	Q9BTT0
IFGDTEDVAGKAYTG	ATP2A3	641	Q93084
AEYGRLGLGEGAEEK	RCC1	321	P18754
DGTGGQSIYGDKFED	RANBP2	3131	P49792
LCGGDVKGESGYVAS	PCOLCE	36	Q15113
GGGEGKAMYIDTEGT	RAD51	151	Q06609
YENGEIGESQVKGGE	ITPR2	1136	Q14571
GGFTSYIAKGEDEEL	OGFOD1	476	Q8N543
KMYGAQEDGSVGEGD	LPCAT1	426	Q8NF37
GKGYGSESGEEDFAA	NEIL1	241	Q96FI4
TAAKYGRLDSEEGDG	DDR2	56	Q16832
VGESVDDCGGGYSES	HERC2	4471	O95714
GREKEAGYSAAVGVG	IQSEC2	181	Q5JU85
EGEDGKLFIGTAVDG	PLXNA2	176	O75051
GGVYGELKTFNSDGE	KIAA0232	931	Q92628
EGTAEDQKGGAAYTD	PDE2A	211	O00408
SSTDKSDGDYGEGKG	NEK4	686	P51957
SDGDYGEGKGQTNEI	NEK4	691	P51957
DDDGLVISGYGSGET	NRXN3	1401	Q9Y4C0
YDGLGTTLDAEKGVD	LRP2BP	101	Q9P2M1
EGKIYTSGGSEVGNS	KLHL7	381	Q8IXQ5
EEGDKYVVVDSGGGT	HSPA12A	306	O43301
ERDSYTIGVEAKDGG	PCDHGB3	311	Q9Y5G1
EYAGGGELFGKISTE	NIM1K	151	Q8IY84
EEISYTGSDGIEGGL	BPNT2	321	Q9NX62
IEQGSAGKVTTDYGE	DZIP3	731	Q86Y13
LYGDGKDGDTQTDAG	HTATSF1	21	O43719
TGSLEKGEEQYGADG	NCOA6	1836	Q14686
KGEEQYGADGETEGQ	NCOA6	1841	Q14686
YGADGETEGQGLDTT	NCOA6	1846	Q14686
KTGGSGEAYDIIAED	KDM1B	771	Q8NB78
SDKDLEDIVGGGEYK	CD99L2	146	Q8TCZ2
EGVELGADGKTVSYT	CABLES1	386	Q8TDN4
GFEGSKGETGEKGEQ	COL19A1	331	Q14993
LEDTDGDGDSGKYAF	DDX51	461	Q8N8A6
FNVDGSKEAGAEGIG	FRMPD2	706	Q68DX3
GGKAVANYDSVEEGE	HSD17B4	66	P51659
AGGESTKGYTAEQVA	DNAJB12	86	Q9NXW2
GAGKEEDVGIGDYDY	COL5A1	326	P20908
SHGDKGIIYGTDGQE	CASP8	316	Q14790
ESVKGVGQGDTGRYA	DSC1	801	Q08554
DVVKTGIEQGSDAGY	HADHA	306	P40939
GAGDDGGGYTVEVSI	EFNA2	51	O43921
EGTVKYTLSGDGAGT	CDH12	86	P55289
DSYDVKSGVAVGGLA	COL3A1	156	P02461
DEGDGAIKYTISGEG	CDH22	91	Q9UJ99
VVSGATDGIGKAYAE	HSDL1	71	Q3SXM5
IKEEGAYETGSGGAE	HIC2	471	Q96JB3
YLKDGNSSKGTEGDG	RUFY3	241	Q7L099
RIGFGTGKSYGTEVD	SYTL2	881	Q9HCH5
SETGDYGNVKVSGEI	SYTL5	396	Q8TDW5
VGKEAEGAGEESSGV	SNX4	31	O95219
ETEGIGDGDLTKYQS	SUSD5	456	O60279
NGTGGKSIYGEKFED	PPIA	71	P62937
TLDGGAIYEAGKEHG	MELTF	76	P08582
GSARGDKEGDIDYST	TMCO3	401	Q6UWJ1
GDFSEGNGKGGESIY	NKTR	76	P30414
IEDTYGAGGGEACEI	NPHP3	16	Q7Z494
LSESGSDSDVGYGGI	TAF1L	1791	Q8IZX4
GGTGAGKAECGYETE	PRDM15	206	P57071
VAYEGSDSEKGEGAE	NTHL1	66	P78549
DDGLVISGYGSGETF	NRXN3	396	Q9HDB5
NGTGGESIYGEKFED	PPID	91	Q08752
AKSSVGETVYGGSDE	SUPT5H	146	O00267
QEGRASGTVYSGEEK	SGPL1	141	O95470
GYSTETGEKGAQLSG	ABCB9	631	Q9NP78
SGLVYKSGSGEIGSE	UHRF1BP1L	981	A0JNW5
SGLALYDGKDGTDGE	ZCCHC8	331	Q6NZY4
YDGKDGTDGETEVGE	ZCCHC8	336	Q6NZY4
GEQGVDEGGVSKEFF	UBE3A	561	Q05086
KYAAPSKEEEGGGDG	TTI2	91	Q6NXR4
LYDSEGLSGEERGGK	SCAF1	731	Q9H7N4
GQYDGSAGVDTGAVE	ZNF609	196	O15014
KGMDSGFAGGEDEIY	SNW1	416	Q13573
TGGTKDYIVVGSDSG	SF3B3	71	Q15393
GESGTFYEGTDDKVR	MAP2	891	P11137
AVAVGSGGSYGAEDE	YIPF2	41	Q9BWQ6
EKEGEDGYGKLGRQD	ZEB2	1141	O60315
GDLAAIEAYKSSGGD	ZRANB1	276	Q9UGI0
VGGSGGKTLEDVFYE	ATP6V0D2	281	Q8N8Y2
FRTVEGTAKGGGEDF	SLC8A3	566	P57103
GTAKGGGEDFEDTYG	SLC8A3	571	P57103
DELNTGKGEGVAYRG	MYOF	521	Q9NZM1
GYGVDSDGSEDTEVK	MYT1	86	Q01538